Dose–Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light–Dark Test in Mice
Sign Up to like & getrecommendations! Published in 2018 at "Dose-Response"
DOI: 10.1177/1559325818779752
Abstract: Earlier studies have shown that combination of antibodies to S100 protein and to cannabinoid receptor type 1 in released-active form (Brizantin) may possess anxiolytic properties and decrease nicotine dependence. Released-active form of antibodies is a… read more here.
Keywords: s100 protein; antibodies s100; released active; active form ... See more keywords